{
  "DOI": "10.1038/ejhg.2011.89",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2011.89",
  "alternative-id": [
    "BFejhg201189"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Also-Rallo",
      "given": "Eva",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Alías",
      "given": "Laura",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Martínez-Hernández",
      "given": "Rebeca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Caselles",
      "given": "Lidia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Barceló",
      "given": "María J",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Baiget",
      "given": "Montserrat",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bernal",
      "given": "Sara",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tizzano",
      "given": "Eduardo F",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        5,
        25
      ]
    ],
    "date-time": "2011-05-25T10:16:38Z",
    "timestamp": 1306318598000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:05:17Z",
    "timestamp": 1684429517000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        30
      ]
    ],
    "date-time": "2023-10-30T02:30:05Z",
    "timestamp": 1698633005996
  },
  "is-referenced-by-count": 25,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2011,
        5,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2011,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            5,
            25
          ]
        ],
        "date-time": "2011-05-25T00:00:00Z",
        "timestamp": 1306281600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg201189.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg201189",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg201189.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1059-1065",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2011,
        5,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        5,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s00439-008-0598-1",
      "author": "L Alias",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Hum Genet",
      "key": "BFejhg201189_CR1",
      "unstructured": "Alias L, Bernal S, Fuentes-Prior P et al: Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet 2009; 125: 29–39.",
      "volume": "125",
      "year": "2009"
    },
    {
      "DOI": "10.1016/0092-8674(95)90460-3",
      "author": "S Lefebvre",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Cell",
      "key": "BFejhg201189_CR2",
      "unstructured": "Lefebvre S, Burglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155–165.",
      "volume": "80",
      "year": "1995"
    },
    {
      "DOI": "10.1038/ng1195-335",
      "author": "E Bussaglia",
      "doi-asserted-by": "publisher",
      "first-page": "335",
      "journal-title": "Nat Genet",
      "key": "BFejhg201189_CR3",
      "unstructured": "Bussaglia E, Clermont O, Tizzano E et al: A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet 1995; 11: 335–337.",
      "volume": "11",
      "year": "1995"
    },
    {
      "DOI": "10.1002/humu.10245",
      "author": "I Cusco",
      "doi-asserted-by": "publisher",
      "first-page": "136",
      "journal-title": "Hum Mutat",
      "key": "BFejhg201189_CR4",
      "unstructured": "Cusco I, Lopez E, Soler-Botija C, Jesus Barcelo M, Baiget M, Tizzano EF : A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene. Hum Mutat 2003; 22: 136–143.",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s00439-002-0681-y",
      "author": "Y Martin",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "Hum Genet",
      "key": "BFejhg201189_CR5",
      "unstructured": "Martin Y, Valero A, del Castillo E, Pascual SI, Hernandez-Chico C : Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations. Hum Genet 2002; 110: 257–263.",
      "volume": "110",
      "year": "2002"
    },
    {
      "DOI": "10.1073/pnas.96.11.6307",
      "author": "CL Lorson",
      "doi-asserted-by": "publisher",
      "first-page": "6307",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg201189_CR6",
      "unstructured": "Lorson CL, Hahnen E, Androphy EJ, Wirth B : A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999; 96: 6307–6311.",
      "volume": "96",
      "year": "1999"
    },
    {
      "DOI": "10.1093/hmg/8.7.1177",
      "author": "UR Monani",
      "doi-asserted-by": "publisher",
      "first-page": "1177",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201189_CR7",
      "unstructured": "Monani UR, Lorson CL, Parsons DW et al: A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 1999; 8: 1177–1183.",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.1006/bbrc.1995.2135",
      "author": "M Gennarelli",
      "doi-asserted-by": "publisher",
      "first-page": "342",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "BFejhg201189_CR8",
      "unstructured": "Gennarelli M, Lucarelli M, Capon F et al: Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 1995; 213: 342–348.",
      "volume": "213",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0014-5793(01)02330-4",
      "author": "E Dodds",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "FEBS Lett",
      "key": "BFejhg201189_CR9",
      "unstructured": "Dodds E, Dunckley MG, Roberts RG, Muntoni F, Shaw CE : Overexpressed human survival motor neurone isoforms, SMNDeltaexon7 and SMN+exon7, both form intranuclear gems but differ in cytoplasmic distribution. FEBS Lett 2001; 495: 31–38.",
      "volume": "495",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/9.2.259",
      "author": "CL Lorson",
      "doi-asserted-by": "publisher",
      "first-page": "259",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201189_CR10",
      "unstructured": "Lorson CL, Androphy EJ : An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 2000; 9: 259–265.",
      "volume": "9",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s00415-005-0912-y",
      "author": "I Cusco",
      "doi-asserted-by": "publisher",
      "first-page": "21",
      "journal-title": "J Neurol",
      "key": "BFejhg201189_CR11",
      "unstructured": "Cusco I, Barcelo MJ, Rojas-Garcia R et al: SMN2 copy number predicts acute or chronic spinal muscular atrophy but does not account for intrafamilial variability in siblings. J Neurol 2006; 253: 21–25.",
      "volume": "253",
      "year": "2006"
    },
    {
      "DOI": "10.1086/338627",
      "author": "M Feldkotter",
      "doi-asserted-by": "publisher",
      "first-page": "358",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg201189_CR12",
      "unstructured": "Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B : Quantitative analyses of SMN1 and SMN2 based on real-time light cycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358–368.",
      "volume": "70",
      "year": "2002"
    },
    {
      "DOI": "10.1073/pnas.171105098",
      "author": "JG Chang",
      "doi-asserted-by": "publisher",
      "first-page": "9808",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg201189_CR13",
      "unstructured": "Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H : Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808–9813.",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1517/13543784.11.12.1695",
      "author": "WK Kelly",
      "doi-asserted-by": "publisher",
      "first-page": "1695",
      "journal-title": "Expert Opin Investig Drugs",
      "key": "BFejhg201189_CR14",
      "unstructured": "Kelly WK, O'Connor OA, Marks PA : Histone deacetylase inhibitors: from target to clinical trials. Expert Opin Investig Drugs 2002; 11: 1695–1713.",
      "volume": "11",
      "year": "2002"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201102",
      "author": "C Andreassi",
      "doi-asserted-by": "publisher",
      "first-page": "59",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg201189_CR15",
      "unstructured": "Andreassi C, Angelozzi C, Tiziano FD et al: Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet 2004; 12: 59–65.",
      "volume": "12",
      "year": "2004"
    },
    {
      "DOI": "10.1093/hmg/ddg256",
      "author": "L Brichta",
      "doi-asserted-by": "publisher",
      "first-page": "2481",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201189_CR16",
      "unstructured": "Brichta L, Hofmann Y, Hahnen E et al: Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003; 12: 2481–2489.",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ana.10743",
      "author": "CJ Sumner",
      "doi-asserted-by": "publisher",
      "first-page": "647",
      "journal-title": "Ann Neurol",
      "key": "BFejhg201189_CR17",
      "unstructured": "Sumner CJ, Huynh TN, Markowitz JA et al: Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 2003; 54: 647–654.",
      "volume": "54",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ana.20548",
      "author": "SM Grzeschik",
      "doi-asserted-by": "publisher",
      "first-page": "194",
      "journal-title": "Ann Neurol",
      "key": "BFejhg201189_CR18",
      "unstructured": "Grzeschik SM, Ganta M, Prior TW, Heavlin WD, Wang CH : Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol 2005; 58: 194–202.",
      "volume": "58",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201320",
      "author": "C Brahe",
      "doi-asserted-by": "publisher",
      "first-page": "256",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg201189_CR19",
      "unstructured": "Brahe C, Vitali T, Tiziano FD et al: Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients. Eur J Hum Genet 2005; 13: 256–259.",
      "volume": "13",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ana.20836",
      "author": "L Brichta",
      "doi-asserted-by": "publisher",
      "first-page": "970",
      "journal-title": "Ann Neurol",
      "key": "BFejhg201189_CR20",
      "unstructured": "Brichta L, Holker I, Haug K, Klockgether T, Wirth B : In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol 2006; 59: 970–975.",
      "volume": "59",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jns.2007.11.012",
      "author": "WC Liang",
      "doi-asserted-by": "publisher",
      "first-page": "87",
      "journal-title": "J Neurol Sci",
      "key": "BFejhg201189_CR21",
      "unstructured": "Liang WC, Yuo CY, Chang JG et al: The effect of hydroxyurea in spinal muscular atrophy cells and patients. J Neurol Sci 2008; 268: 87–94.",
      "volume": "268",
      "year": "2008"
    },
    {
      "DOI": "10.1371/journal.pone.0005268",
      "author": "KJ Swoboda",
      "doi-asserted-by": "publisher",
      "first-page": "e5268",
      "journal-title": "PLoS One",
      "key": "BFejhg201189_CR22",
      "unstructured": "Swoboda KJ, Scott CB, Reyna SP et al: Phase II open label study of valproic acid in spinal muscular atrophy. PLoS One 2009; 4: e5268.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1212/WNL.0b013e3182020332",
      "author": "TH Chen",
      "doi-asserted-by": "publisher",
      "first-page": "2190",
      "journal-title": "Neurology",
      "key": "BFejhg201189_CR23",
      "unstructured": "Chen TH, Chang JG, Yang YH et al: Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy. Neurology 2010; 75: 2190–2197.",
      "volume": "75",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S0960-8966(06)80015-5",
      "author": "TL Munsat",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg201189_CR24",
      "unstructured": "Munsat TL, Davies KE : International SMA consortium meeting. (26–28 June 1992, Bonn, Germany). Neuromuscul Disord 1992; 2: 423–428.",
      "volume": "2",
      "year": "1992"
    },
    {
      "DOI": "10.1006/geno.1996.0147",
      "author": "L Burglen",
      "doi-asserted-by": "publisher",
      "first-page": "479",
      "journal-title": "Genomics",
      "key": "BFejhg201189_CR25",
      "unstructured": "Burglen L, Lefebvre S, Clermont O et al: Structure and organization of the human survival motor neurone (SMN) gene. Genomics 1996; 32: 479–482.",
      "volume": "32",
      "year": "1996"
    },
    {
      "DOI": "10.1093/jnen/64.3.215",
      "author": "C Soler-Botija",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "journal-title": "J Neuropathol Exp Neurol",
      "key": "BFejhg201189_CR26",
      "unstructured": "Soler-Botija C, Cusco I, Caselles L, Lopez E, Baiget M, Tizzano EF : Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function? J Neuropathol Exp Neurol 2005; 64: 215–223.",
      "volume": "64",
      "year": "2005"
    },
    {
      "DOI": "10.1016/0162-3109(80)90052-1",
      "author": "RI Mishell",
      "doi-asserted-by": "publisher",
      "first-page": "233",
      "journal-title": "Immunopharmacology",
      "key": "BFejhg201189_CR27",
      "unstructured": "Mishell RI, Shiigi JM, Mishell BB, Grabstein KH, Shiigi SM : Prevention of the immunosuppressive effects of glucocorticosteroids by cell-free factors from adjuvant-activated accessory cells. Immunopharmacology 1980; 2: 233–245.",
      "volume": "2",
      "year": "1980"
    },
    {
      "DOI": "10.1212/01.wnl.0000252934.70676.ab",
      "author": "LR Simard",
      "doi-asserted-by": "publisher",
      "first-page": "451",
      "journal-title": "Neurology",
      "key": "BFejhg201189_CR28",
      "unstructured": "Simard LR, Belanger MC, Morissette S, Wride M, Prior TW, Swoboda KJ : Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA. Neurology 2007; 68: 451–456.",
      "volume": "68",
      "year": "2007"
    },
    {
      "DOI": "10.1093/hmg/6.8.1205",
      "author": "DD Coovert",
      "doi-asserted-by": "publisher",
      "first-page": "1205",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201189_CR29",
      "unstructured": "Coovert DD, Le TT, McAndrew PE et al: The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997; 6: 1205–1214.",
      "volume": "6",
      "year": "1997"
    },
    {
      "DOI": "10.1038/ng0797-265",
      "author": "S Lefebvre",
      "doi-asserted-by": "publisher",
      "first-page": "265",
      "journal-title": "Nat Genet",
      "key": "BFejhg201189_CR30",
      "unstructured": "Lefebvre S, Burlet P, Liu Q et al: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997; 16: 265–269.",
      "volume": "16",
      "year": "1997"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200286",
      "author": "AL Patrizi",
      "doi-asserted-by": "publisher",
      "first-page": "301",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg201189_CR31",
      "unstructured": "Patrizi AL, Tiziano F, Zappata S, Donati MA, Neri G, Brahe C : SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis. Eur J Hum Genet 1999; 7: 301–309.",
      "volume": "7",
      "year": "1999"
    },
    {
      "DOI": "10.1212/01.wnl.0000201929.56928.13",
      "author": "CJ Sumner",
      "doi-asserted-by": "publisher",
      "first-page": "1067",
      "journal-title": "Neurology",
      "key": "BFejhg201189_CR32",
      "unstructured": "Sumner CJ, Kolb SJ, Harmison GG et al: SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials. Neurology 2006; 66: 1067–1073.",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s00439-003-1025-2",
      "author": "C Helmken",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Hum Genet",
      "key": "BFejhg201189_CR33",
      "unstructured": "Helmken C, Hofmann Y, Schoenen F et al: Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum Genet 2003; 114: 11–21.",
      "volume": "114",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S1074-5521(02)00092-3",
      "author": "CM Grozinger",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Chem Biol",
      "key": "BFejhg201189_CR34",
      "unstructured": "Grozinger CM, Schreiber SL : Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem Biol 2002; 9: 3–16.",
      "volume": "9",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0092-8674(00)80211-1",
      "author": "MJ Pazin",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "journal-title": "Cell",
      "key": "BFejhg201189_CR35",
      "unstructured": "Pazin MJ, Kadonaga JT : What's up and down with histone deacetylation and transcription? Cell 1997; 89: 325–328.",
      "volume": "89",
      "year": "1997"
    },
    {
      "DOI": "10.1093/hmg/ddi130",
      "author": "LE Kernochan",
      "doi-asserted-by": "publisher",
      "first-page": "1171",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201189_CR36",
      "unstructured": "Kernochan LE, Russo ML, Woodling NS et al: The role of histone acetylation in SMN gene expression. Hum Mol Genet 2005; 14: 1171–1182.",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s10048-010-0268-z",
      "author": "C Xu",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "journal-title": "Neurogenetics",
      "key": "BFejhg201189_CR37",
      "unstructured": "Xu C, Chen X, Grzeschik S, Ganta M, Wang C : Hydroxyurea enhances SMN2 gene expression through nitric oxide release. Neurogenetics 2011; 12: 19–24.",
      "volume": "12",
      "year": "2011"
    },
    {
      "author": "T Davis",
      "first-page": "4334",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg201189_CR38",
      "unstructured": "Davis T, Kennedy C, Chiew YE, Clarke CL, deFazio A : Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Clin Cancer Res 2000; 6: 4334–4342.",
      "volume": "6",
      "year": "2000"
    },
    {
      "author": "SA McGrath-Morrow",
      "first-page": "941",
      "journal-title": "J Pharmacol Exp Ther",
      "key": "BFejhg201189_CR39",
      "unstructured": "McGrath-Morrow SA, Stahl JL : G(1) Phase growth arrest and induction of p21(Waf1/Cip1/Sdi1) in IB3-1 cells treated with 4-sodium phenylbutyrate. J Pharmacol Exp Ther 2000; 294: 941–947.",
      "volume": "294",
      "year": "2000"
    },
    {
      "DOI": "10.1093/toxsci/kfp002",
      "author": "M Jergil",
      "doi-asserted-by": "publisher",
      "first-page": "132",
      "journal-title": "Toxicol Sci",
      "key": "BFejhg201189_CR40",
      "unstructured": "Jergil M, Kultima K, Gustafson AL, Dencker L, Stigson M : Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects. Toxicol Sci 2009; 108: 132–148.",
      "volume": "108",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.mrfmmm.2003.08.017",
      "author": "EM Hammond",
      "doi-asserted-by": "publisher",
      "first-page": "205",
      "journal-title": "Mutat Res",
      "key": "BFejhg201189_CR41",
      "unstructured": "Hammond EM, Green SL, Giaccia AJ : Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat Res 2003; 532: 205–213.",
      "volume": "532",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s12325-008-0030-1",
      "author": "D Dayangac-Erden",
      "doi-asserted-by": "publisher",
      "first-page": "274",
      "journal-title": "Adv Ther",
      "key": "BFejhg201189_CR42",
      "unstructured": "Dayangac-Erden D, Topaloglu H, Erdem-Yurter H : A preliminary report on spinal muscular atrophy lymphoblastoid cell lines: are they an appropriate tool for drug screening? Adv Ther 2008; 25: 274–279.",
      "volume": "25",
      "year": "2008"
    },
    {
      "DOI": "10.1093/hmg/ddn357",
      "author": "J Hauke",
      "doi-asserted-by": "publisher",
      "first-page": "304",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201189_CR43",
      "unstructured": "Hauke J, Riessland M, Lunke S et al: Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet 2009; 18: 304–317.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1136/jmg.2010.079004",
      "author": "S Bernal",
      "doi-asserted-by": "publisher",
      "first-page": "640",
      "journal-title": "J Med Genet",
      "key": "BFejhg201189_CR44",
      "unstructured": "Bernal S, Alias L, Barcelo MJ et al: The c.859G\u0026gt;C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor. J Med Genet 2011; 47: 640–642.",
      "volume": "47",
      "year": "2011"
    },
    {
      "DOI": "10.1212/01.wnl.0000249142.82285.d6",
      "author": "E Mercuri",
      "doi-asserted-by": "publisher",
      "first-page": "51",
      "journal-title": "Neurology",
      "key": "BFejhg201189_CR45",
      "unstructured": "Mercuri E, Bertini E, Messina S et al: Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology 2007; 68: 51–55.",
      "volume": "68",
      "year": "2007"
    },
    {
      "DOI": "10.1093/hmg/ddp313",
      "author": "L Garbes",
      "doi-asserted-by": "publisher",
      "first-page": "3645",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201189_CR46",
      "unstructured": "Garbes L, Riessland M, Holker I et al: LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum Mol Genet 2009; 18: 3645–3658.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ejhg.2009.116",
      "author": "FD Tiziano",
      "doi-asserted-by": "publisher",
      "first-page": "52",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg201189_CR47",
      "unstructured": "Tiziano FD, Pinto AM, Fiori S et al: SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. Eur J Hum Genet 2010; 18: 52–58.",
      "volume": "18",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature07677",
      "author": "AD Ebert",
      "doi-asserted-by": "publisher",
      "first-page": "277",
      "journal-title": "Nature",
      "key": "BFejhg201189_CR48",
      "unstructured": "Ebert AD, Yu J, Rose Jr FF et al: Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277–280.",
      "volume": "457",
      "year": "2009"
    }
  ],
  "reference-count": 48,
  "references-count": 48,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg201189"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability"
  ],
  "type": "journal-article",
  "volume": "19"
}